• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for Malaria.com

Anti-Infective Drugs Market to Reach $66 Billion by 2013, Says Report

October 15, 2010 By Malaria.com Leave a Comment

The anti-infective drugs market will jump to $66 billion by 2013, according to a recently published report. Anti-infective drugs include: anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Six infectious diseases -- pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS -- account for half of all premature deaths worldwide. … [Read more...]

Filed Under: Malaria News Tagged With: Abraxis Bioscience, Acambis, Achillion, Acute Suppurative Thyroiditis, Adlyfe, Advanced Life Sciences Holdings, Affinium, Akonni Biosystems, Alnylam, Anti-fungal Agents, Anti-Infective Drugs, Anti-viral Therapeutics, Antibiotics, APP, Aquapharm Biodiscovery, Arbor Vita, Arpida, Avexa, Avian Bird Flu, Basilea, Baxter, Biophage Pharma, Blood-Borne Infections, CEL-SCI, Cerexa, Combimatrix, Complicated Skin and Skin Structure Infections, cSSSI, Cubist, Daiichi Sankyo, Diarrhea, Hospira, Idenix, Incyte, Influenza, Lymphadenitis, Malaria, Measles, Medivir, Meiji Holdings, MerLion, Mutabilis, Nanobio, Nanosphere, Nanoviricides, Novabay, Obetech, Optimer, Panacos, Pancreatitis, Paratek, Pharmasset, Pharyngotonsillitis, Pico, Pneumonia, Polymedix, Powdermed, Presidio, Progenics, Prophylactic Treatments, Protez, Reye's Syndrome, Rib-X, Ribomed, Sinusitis, Targanta, Theravance, Trius, Tuberculosis, Urinary Tract Infections, UTI, Vascular Infections, Vertex, Viral Encephalitis, West Nile Virus, X-GEN

Research Leads to Promising Malaria Drug Candidate

September 20, 2010 By Malaria.com Leave a Comment

A chemical that rid mice of malaria-causing parasites after a single oral dose may eventually become a new malaria drug if further tests in animals and people uphold the promise of early findings. The compound, NITD609, was developed by an international team of researchers including Elizabeth A. Winzeler, Ph.D., a grantee of the National Institute of Allergy and Infectious Diseases (NIAID), part … [Read more...]

Filed Under: Malaria News Tagged With: Anthony S. Fauci, artemisinins, Elizabeth A. Winzeler, Genomic Institute of the Novartis Research Foundation, Malaria Drugs, National Institutes of Health, NIH, NITD609, Novartis Institute for Tropical Diseases (NITD), Plasmodium Falciparum, Scripps Research Institute, Thierry T. Diagana

Anopheles Mosquitoes

September 13, 2010 By Malaria.com Leave a Comment

Anopheles Mosquitoes Diagram of Adult Female Mosquito   Malaria is transmitted among humans by female mosquitoes of the genus Anopheles. Female mosquitoes take blood meals to carry out egg production, and such blood meals are the link between the human and the mosquito hosts in the parasite life cycle. The successful development of the malaria parasite in the mosquito … [Read more...]

Filed Under: Malaria Overview Tagged With: Anopheles Mosquitoes

NITD609 Compound May Be Promising Malaria Drug Candidate, Say Researchers

September 3, 2010 By Malaria.com Leave a Comment

A chemical that rid mice of malaria-causing parasites after a single oral dose may eventually become a new malaria drug if further tests in animals and people uphold the promise of early findings. The compound, NITD609, was developed by an international team of researchers. “Although significant progress has been made in controlling malaria, the disease still kills nearly 1 million people every … [Read more...]

Filed Under: Malaria News, Malaria Research Tagged With: Anthony S. Fauci, Artemisinin, Elizabeth A. Winzeler, NITD609, Plasmodium Falciparum, Spiroindolones, Thierry T. Diagana

Screening Mosquito House Entry Points as a Potential Method for Integrated Control of Malaria

August 3, 2010 By Malaria.com 1 Comment

Partial mosquito-proofing of houses with screens and ceilings has the potential to reduce indoor densities of malaria mosquitoes. We wish to measure whether it will also reduce indoor densities of vectors of neglected tropical diseases. Methodology: The main house entry points preferred by anopheline and culicine vectors were determined through controlled experiments using specially … [Read more...]

Filed Under: Transmission & Vectors Tagged With: Addessium Foundation, Anopheline Vectors, Arbovirus, CDC, Chikungunya, Culex, Culicine Vectors, Endophagic Filariasis, Endophagic Mosquitoes, O'Nyong Nyong, Research Career Development Fellowship, Rift Valley Fever, Screening, Tanzania, U.S. President's Malaria Initiative, Valent Bioscience Corporation

The Effects of Maternal Helminth and Malaria Infections on Mother-to-Child HIV Transmission

November 4, 2005 By Malaria.com Leave a Comment

Objective: To investigate the effect of helminth and/or malaria infection on the risk of HIV infection in pregnant women and its transmission to their offspring. Design: A retrospective cohort study of pregnant Kenyan women and their offspring from term, uncomplicated vaginal deliveries (n = 936) with a nested case-control study. Methods: We determined the presence of HIV, malaria, … [Read more...]

Filed Under: Malaria Research Tagged With: Helminths, HIV, Kenya, Lymphatic Filariasis, Schistosomiasis

« Previous Page

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2025 Malaria.com · Log in